ATE431146T1 - Pharmazeutische zusammensetzung mit einem 1-(3- chlorphenyl)-3-alkylpiperazin zur behandlung von appetitstörungen - Google Patents

Pharmazeutische zusammensetzung mit einem 1-(3- chlorphenyl)-3-alkylpiperazin zur behandlung von appetitstörungen

Info

Publication number
ATE431146T1
ATE431146T1 AT06754160T AT06754160T ATE431146T1 AT E431146 T1 ATE431146 T1 AT E431146T1 AT 06754160 T AT06754160 T AT 06754160T AT 06754160 T AT06754160 T AT 06754160T AT E431146 T1 ATE431146 T1 AT E431146T1
Authority
AT
Austria
Prior art keywords
alkylpiperazine
chlorphenyl
treatment
pharmaceutical composition
composition containing
Prior art date
Application number
AT06754160T
Other languages
English (en)
Inventor
Beatrice Garrone
Maurizio Magnani
Guido Furlotti
Nicola Cazzolla
Angelo Guglielmotti
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Application granted granted Critical
Publication of ATE431146T1 publication Critical patent/ATE431146T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT06754160T 2005-06-24 2006-06-02 Pharmazeutische zusammensetzung mit einem 1-(3- chlorphenyl)-3-alkylpiperazin zur behandlung von appetitstörungen ATE431146T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001193A ITMI20051193A1 (it) 2005-06-24 2005-06-24 Uso farmaceutico di una 1-3-clorofenil-3-alchilpiperazina
PCT/EP2006/005390 WO2006136284A1 (en) 2005-06-24 2006-06-02 Pharmaceutical composition comprising a 1-(3-chlorophenyl)-3-alkylpiperazine for treating apetite disorder

Publications (1)

Publication Number Publication Date
ATE431146T1 true ATE431146T1 (de) 2009-05-15

Family

ID=35198058

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06754160T ATE431146T1 (de) 2005-06-24 2006-06-02 Pharmazeutische zusammensetzung mit einem 1-(3- chlorphenyl)-3-alkylpiperazin zur behandlung von appetitstörungen

Country Status (23)

Country Link
US (1) US7879836B2 (de)
EP (1) EP1893208B1 (de)
JP (1) JP5142991B2 (de)
KR (1) KR101324689B1 (de)
CN (1) CN101171011B (de)
AR (1) AR054491A1 (de)
AT (1) ATE431146T1 (de)
AU (1) AU2006261296B9 (de)
BR (1) BRPI0611719A2 (de)
CA (1) CA2604584C (de)
DE (1) DE602006006827D1 (de)
DK (1) DK1893208T3 (de)
EA (1) EA012443B1 (de)
ES (1) ES2325744T3 (de)
GE (1) GEP20094787B (de)
IL (1) IL186334A (de)
IT (1) ITMI20051193A1 (de)
MX (1) MX2007014396A (de)
PL (1) PL1893208T3 (de)
PT (1) PT1893208E (de)
SI (1) SI1893208T1 (de)
UA (1) UA89236C2 (de)
WO (1) WO2006136284A1 (de)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3253989A (en) * 1963-02-11 1966-05-31 American Cyanamid Co Process for producing anorexia
US3637705A (en) * 1968-10-01 1972-01-25 Abbott Lab N-3 4-dihalo phenyl piperazines
FR2201084B1 (de) * 1972-09-29 1975-10-31 Bouchara Emile
IT1258790B (it) * 1992-01-17 1996-02-29 Angelini Francesco Ist Ricerca Alchil derivati del trazodone
SE9904723D0 (sv) * 1999-12-22 1999-12-22 Carlsson A Research Ab New modulators of dopamine neurotransmission II
EP1644347A1 (de) * 2003-06-20 2006-04-12 Arena Pharmaceuticals, Inc. N-phenylpiperazinderivate und verfahren zur prophylaxe bzw. behandlung von mit dem 5ht[2c]-rezeptor assoziierten krankheiten

Also Published As

Publication number Publication date
DK1893208T3 (da) 2009-08-31
AR054491A1 (es) 2007-06-27
CN101171011A (zh) 2008-04-30
AU2006261296B9 (en) 2011-01-20
US20090054461A1 (en) 2009-02-26
KR20080026115A (ko) 2008-03-24
ES2325744T3 (es) 2009-09-15
PT1893208E (pt) 2009-06-26
CA2604584A1 (en) 2006-12-28
MX2007014396A (es) 2008-02-12
DE602006006827D1 (de) 2009-06-25
KR101324689B1 (ko) 2013-11-04
PL1893208T3 (pl) 2009-10-30
SI1893208T1 (sl) 2009-10-31
IL186334A0 (en) 2008-08-07
GEP20094787B (en) 2009-09-25
JP2008546725A (ja) 2008-12-25
EP1893208A1 (de) 2008-03-05
ITMI20051193A1 (it) 2006-12-25
AU2006261296A1 (en) 2006-12-28
EP1893208B1 (de) 2009-05-13
UA89236C2 (ru) 2010-01-11
CA2604584C (en) 2013-07-16
IL186334A (en) 2011-02-28
AU2006261296B2 (en) 2010-12-16
US7879836B2 (en) 2011-02-01
EA012443B1 (ru) 2009-10-30
JP5142991B2 (ja) 2013-02-13
CN101171011B (zh) 2011-04-13
HK1111080A1 (en) 2008-08-01
EA200800125A1 (ru) 2008-04-28
BRPI0611719A2 (pt) 2012-07-31
WO2006136284A1 (en) 2006-12-28

Similar Documents

Publication Publication Date Title
ATE484494T1 (de) Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen
EP1851237A4 (de) Pharmazeutische zusammensetzungen zur behandlung oder prävention von knochenerkrankungen
ATE532518T1 (de) Dipeptidyl-peptidase-hemmer zur behandlung von diabetes
GB0522311D0 (en) Pharmaceutical compositions for the treatment of pain
ATE542823T1 (de) 4,5-dihydro-ä1,2,4ütriazoloä4,3-füpteridine als plk1-proteinkinasehemmer zur behandlung proliferativer erkrankungen
ZA200610055B (en) Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
DE602006019560D1 (de) 2-cyanobenzolsulfonamidverbindungen zur behandlung von samen
ATE550338T1 (de) Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
ATE512948T1 (de) Biphenyl-sulfonyl- und phenyl-heteroaryl-sulfonyl-modulatoren des histamin-h3-rezeptors zur behandlung von damit verbundenen erkrankungen
IL190652A0 (en) Novel pharmaceutical combinations for the treatment of respiratory disorders
ATE429218T1 (de) Pinolensäure zur behandlung von übergewicht
DE602005017503D1 (de) Biphenyloxyessigsäure - derivate zur behandlung von atemwegserkränkungen
ATE521365T1 (de) Kinin-antagonisten zur behandlung von blasenfunktionsstörung
ZA200805761B (en) Pharmaceutical composition for the treatment of nail disease
DE602007011398D1 (de) Trialkylsilylbenzylaminocarboxyindole, indazole und indoline und ihre verwendung zur behandlung von cetp-vermittelten erkrankungen
DK3072507T3 (da) Farmaceutiske sammensætninger til glukokortikoidsubstitutionsterapi
PT1781298E (pt) Combinações farmacêuticas contendo benzoxazinas para o tratamento de doenças respiratórias
DE502005010499D1 (de) Implantat zur Behandlung von Fettsucht
DE602004021435D1 (de) Injizierbare zusammensetzung zur behandlung von krebs
DE602006017367D1 (de) Amino-oxo-indolyliden-verbindungen zur verwendung in der behandlung von juckender kopfhaut
DE602005016141D1 (de) S-mirtazapin zur behandlung von hitzewallungen
DE602006003094D1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit
IL182692A (en) Use of vlp and amyloid-beta peptide for the manufacture of pharmaceutical compositions for the treatment of dementia
DE602004010172D1 (de) Pharmazeutische zusammensetzungen zur behandlung von nierenfunktionsstörungen
DE602006013009D1 (de) Pharmazeutische zusammensetzung von mahanin zur behandlung von prostatakrebs

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1893208

Country of ref document: EP